Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Domenico Russo, Cyrus Badshah, Valerie Teal et al.|The Lancet Haematology|2023

Cited by 100